Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 5.37 | 9.24 |
| PEG Ratio (TTM) | 0.16 | -0.64 |
| P/S Ratio (TTM) | 0.71 | 0.86 |
| P/B Ratio (TTM) | 0.71 | 1.10 |
| P/FCF Ratio (TTM) | 4.63 | 4.32 |
| Price to 5YR AVG Earnings Ratio | 18.17 | 10.80 |
| Price to 5YR AVG FCF Ratio | -8.64 | 5.34 |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.39% | 3.71% |
| ROE (TTM) | 13.95% | 19.73% |
| Net Profit Margin (TTM) | 12.90% | 15.67% |
| ROIC 5YR AVG | 32.84% | 9.10% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 89.99% | 220.84% | 189.91% |
| Revenue | 3.70% | 39.53% | 28.35% |
| Net Income | 88.83% | 216.84% | 187.47% |
| Cash Flow | 83.78% | -1,852.70% | -1,078.20% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 8.35 |
| Quick Ratio (TTM) | N/A | 7.51 |
| D/E Ratio (TTM) | 0.09 | 0.33 |
| Interest Coverage (TTM) | 4.99 | 23.94 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 1.65 | 0.99 |
| LTL to 5YR AVG FCF | -1.31 | 1.76 |
| Shares Outstanding Growth 5YR AVG | -1.04% | 732.58% |